Deakin University
Browse

File(s) not publicly available

Combining VELIPARIB (ABT-888) with temozolomide shows strong synergy when treating temozolomide-resistant and recurrent GBM cell lines

conference contribution
posted on 2014-10-01, 00:00 authored by K McDonald, K Nozue-Okada, Mustafa Khasraw
Combining VELIPARIB (ABT-888) with temozolomide shows strong synergy when treating temozolomide-resistant and recurrent GBM cell lines

History

Event

American Association for Cancer Research. Conference (2014 : San Diego, Calif.)

Volume

74

Issue

19

Publisher

American Association for Cancer Research

Location

San Diego, Calif.

Start date

2014-04-05

End date

2014-04-09

ISSN

0008-5472

eISSN

1538-7445

Language

English

Publication classification

E3.1 Extract of paper

Title of proceedings

Proceedings of the AACR Annual Meeting 2014

Usage metrics

    Research Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC